莫德纳公司在2025年1月22日周三的盘中交易中,股价出现大涨14.08%的行情,引起了市场的广泛关注。
导致股价大涨的主要原因是,根据消息,联邦政府已向莫德纳公司拨付了5.9亿美元的资金,用于加速公司禽流感疫苗的研发。这表明政府非常重视禽流感疫苗的研发,并对莫德纳的mRNA技术平台充满信心。
作为全球首家商业化mRNA疫苗的生产商,莫德纳的mRNA新冠疫苗在2020年获批上市后,迅速成为了公司的主要收入来源。现在联邦政府的巨额投资,将进一步推动莫德纳的mRNA技术在其他疫苗领域的应用,打开公司更广阔的市场前景。这就是为何投资者看好公司未来的发展潜力,莫德纳股价因此出现了大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.